Equity Analysis /
United States of America

US : Pharmaceuticals - Specialty Pharmaceuticals | RX Volumes Ex-Vaccines Decline Modestly Sequentially Though 52-Week Numbers Still Pointing Higher

    Contributors
    Michael Parolari
    Lucas Lee
    CGS-CIMB
    19 April 2021
    Published by